David Casalino to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications David Casalino has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.014
-
Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology. 2005 Oct; 237(1):89-98.
Score: 0.014